DV
Dividend Vision

SGMT — Sagimet Biosciences Inc. Series A Common Stock

Sagimet Biosciences Inc. Series A Common Stock (SGMT)

Total return is -33.9% over the past 3.1 years, 113.3 points behind SPY at 79.4%. Its deepest 1-year drawdown was 52.5%.

SGMT is a single-stock holding in Sagimet Biosciences Inc., a biosciences company. The fund does not currently pay distributions and carries no listed expense ratio, reflecting its structure as a direct equity position rather than a diversified fund. This holding appeals primarily to investors seeking exposure to a specific biosciences company rather than those focused on dividend income or broad portfolio diversification.

SGMT key facts

Asset type
Stock
Asset class
Equity
Inception date
07/14/2023
Last close
$10.55
Market cap
$442,142,944
Average volume
2655400.0
Beta
3.381
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.24